ConductScience.org, home

Paper42018554

Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target.

Luk JTF and 10 others. Prostate, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target. Papers, record 42018554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42018554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target.
PubMed
Journal
Prostate
PubMed
Year
2026
PubMed
Publication types
Journal Article, Systematic Review, Meta-Analysis
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-11
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luk JTFJacky T F
2Lin AHAlex H
3Cheung EKCEsther K C
4Meçani RRenald
5Muka TTaulanthttps://orcid.org/0000-0003-3235-3073
6Nano JJana
7Ng JKMJoanna K M
8Chiu MKLMatthew K L
9Li BCWBryan C W
10Na RRong
11Li JJXJoshua J Xhttps://orcid.org/0000-0003-2425-0314

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Erb-b2 Receptor Tyrosine KinasesMajor topic
Humans
Male
Biomarkers, Tumor

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112173324HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.Cancer2002https://conductscience.org/library/papers/12173324PubMed
234016991HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now.NPJ Breast Cancer2021https://conductscience.org/library/papers/34016991PubMed
312365012Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.Cancer2002https://conductscience.org/library/papers/12365012PubMed
420812221Significant prognostic factor of immunohistochemical HER-2 expression using initial prostate biopsy specimens with M1b prostate cancer.Prostate2011https://conductscience.org/library/papers/20812221PubMed
522340411Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer.Chin Med J (Engl)2011https://conductscience.org/library/papers/22340411PubMed
639282896Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.N Engl J Med2024https://conductscience.org/library/papers/39282896PubMed
741124210Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.N Engl J Med2025https://conductscience.org/library/papers/41124210PubMed
838622987The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma.Ann Diagn Pathol2023https://conductscience.org/library/papers/38622987PubMed
938427749Comparison of molecular analysis results determined by next-generation sequencing to immunohistochemical indicators and clinicopathological parameters in prostate adenocarcinomas.Indian J Pathol Microbiol2024https://conductscience.org/library/papers/38427749PubMed
1020690807Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US.Cancer Invest2010https://conductscience.org/library/papers/20690807PubMed
1137628975Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes.Int J Mol Sci2023https://conductscience.org/library/papers/37628975PubMed
1211488070HER2 protein expression and gene amplification in androgen-independent prostate cancer.Am J Clin Pathol2001https://conductscience.org/library/papers/11488070PubMed
1320530441Detection of HER2 amplification using the SISH technique in breast, colon, prostate, lung and ovarian carcinoma.Anticancer Res2010https://conductscience.org/library/papers/20530441PubMed
1437867174Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis.NPJ Breast Cancer2023https://conductscience.org/library/papers/37867174PubMed
1525124637Overexpression of HER-2/neu in patients with prostatic adenocarcinoma.Asian Pac J Cancer Prev2014https://conductscience.org/library/papers/25124637PubMed
1624508693HER2 in breast cancer: a review and update.Adv Anat Pathol2014https://conductscience.org/library/papers/24508693PubMed
1732939066Array programming with NumPy.Nature2020https://conductscience.org/library/papers/32939066PubMed
1834277004The influence of testosterone suppression on HER2 immunoexpression in prostatic neoplastic tissue.Mol Clin Oncol2021https://conductscience.org/library/papers/34277004PubMed
1911207822Overexpression of HER2/neu in solid tumours: an immunohistochemical survey.Histopathology2001https://conductscience.org/library/papers/11207822PubMed
2032015543SciPy 1.0: fundamental algorithms for scientific computing in Python.Nat Methods2020https://conductscience.org/library/papers/32015543PubMed

See all 37 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42018554

GET https://conductscience.org/api/papers/v1/42018554/references?page=2